You are here

  • Home
  • Archive
  • Volume 31, Issue 12
  • A phase III randomized clinical trial comparing sentinel node biopsy with no retroperitoneal node dissection in apparent early-stage endometrial cancer – ENDO-3: ANZGOG trial 1911/2020

Article info

Article menu
Download PDFPDF
Clinical trial
A phase III randomized clinical trial comparing sentinel node biopsy with no retroperitoneal node dissection in apparent early-stage endometrial cancer – ENDO-3: ANZGOG trial 1911/2020

Authors

  1. Correspondence to Professor Andreas Obermair, Queensland Centre for Gynaecological Cancer Research, The University of Queensland, Brisbane, Queensland, Australia; a.obermair{at}uq.edu.au
View Full Text

Citation

Obermair A, Nicklin J, Gebski V, et al
A phase III randomized clinical trial comparing sentinel node biopsy with no retroperitoneal node dissection in apparent early-stage endometrial cancer – ENDO-3: ANZGOG trial 1911/2020
International Journal of Gynecologic Cancer 2021;31:1595-1601.

Publication history

  • Accepted October 13, 2021
  • First published November 2, 2021.
Online issue publication 
December 06, 2021

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© IGCS and ESGO 2021. No commercial re-use. See rights and permissions. Published by BMJ.